This issue of Critical Care Clinics, guest edited by Dr. Mitchell M. Levy, focuses on Biomarkers in Critical Care. This is one of four issues each year selected by the series consulting editor, Dr. John Kellum. Articles in this issue include, but are not limited to: The History of Biomarkers; Biomarkers for Identifying Infection; Procalcitonin: Where Are We Now?; Soluble TREM-1: Diagnosis or Prognosis?; Lubricin as a Biomarker in Sepsis; Check Point Inhibitors and Their Role in Immunosuppression in Sepsis; Metabolomics and the Microbiome as Biomarkers in Sepsis; Lactate: Where Are We Now?; Predicting Renal Dysfunction; Biomarkers in the Evolution of ARDS; Biomarkers and RV Dysfunction; Biomarkers and Precision Medicine: State of the Art; The Use of Biomarkers for Population Homogeneity in Clinical Trials; and The Future of Biomarkers.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xi 7. Preface - p. xiii 8. The History of Biomarkers: How Far Have We Come? - p. 1 9. Biomarkers of Infection and Sepsis - p. 11 10. Procalcitonin: Where Are We Now? - p. 23 11. Soluble Triggering Receptor Expressed on Myeloid Cells-1: Diagnosis or Prognosis? - p. 41 12. Lubricin as a Therapeutic and Potential Biomarker in Sepsis - p. 55 13. Check Point Inhibitors and Their Role in Immunosuppression in Sepsis - p. 69 14. Biomarker Panels in Critical Care - p. 89 15. Metabolomics and the Microbiome as Biomarkers in Sepsis - p. 105 16. Lactate: Where Are We Now? - p. 115 17. The Role of Biomarkers in Acute Kidney Injury - p. 125 18. Biomarkers and Right Ventricular Dysfunction - p. 141 19. Biomarkers and Precision Medicine: State of the Art - p. 155 20. Biomarkers of Immunosuppression - p. 167 21. The Future of Biomarkers - p. 177
No hay muestra disponible
No hay ficha técnica disponible
This issue of Critical Care Clinics, guest edited by Dr. Mitchell M. Levy, focuses on Biomarkers in Critical Care. This is one of four issues each year selected by the series consulting editor, Dr. John Kellum. Articles in this issue include, but are not limited to: The History of Biomarkers; Biomarkers for Identifying Infection; Procalcitonin: Where Are We Now?; Soluble TREM-1: Diagnosis or Prognosis?; Lubricin as a Biomarker in Sepsis; Check Point Inhibitors and Their Role in Immunosuppression in Sepsis; Metabolomics and the Microbiome as Biomarkers in Sepsis; Lactate: Where Are We Now?; Predicting Renal Dysfunction; Biomarkers in the Evolution of ARDS; Biomarkers and RV Dysfunction; Biomarkers and Precision Medicine: State of the Art; The Use of Biomarkers for Population Homogeneity in Clinical Trials; and The Future of Biomarkers.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xi 7. Preface - p. xiii 8. The History of Biomarkers: How Far Have We Come? - p. 1 9. Biomarkers of Infection and Sepsis - p. 11 10. Procalcitonin: Where Are We Now? - p. 23 11. Soluble Triggering Receptor Expressed on Myeloid Cells-1: Diagnosis or Prognosis? - p. 41 12. Lubricin as a Therapeutic and Potential Biomarker in Sepsis - p. 55 13. Check Point Inhibitors and Their Role in Immunosuppression in Sepsis - p. 69 14. Biomarker Panels in Critical Care - p. 89 15. Metabolomics and the Microbiome as Biomarkers in Sepsis - p. 105 16. Lactate: Where Are We Now? - p. 115 17. The Role of Biomarkers in Acute Kidney Injury - p. 125 18. Biomarkers and Right Ventricular Dysfunction - p. 141 19. Biomarkers and Precision Medicine: State of the Art - p. 155 20. Biomarkers of Immunosuppression - p. 167 21. The Future of Biomarkers - p. 177
No hay muestra disponible
No hay ficha técnica disponible
